mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |